Rare diseases
Investigational molecules
Locations
Rydbergs Torg 4, 224 84 Lund, Sweden
Clinical research in acromegaly focuses on long-term disease control, symptom management, and the use of somatostatin analogue therapies in chronic endocrine care.
These studies reflect sustained interest in therapies used to regulate growth hormone-related disorders and associated clinical burden.
Camurus AB runs clinical trials in conditions such as Obesity, Acromegaly, Gastroenteropancreatic neuroendocrine tumour disease, Polycystic liver disease, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Phase 2b Randomized Study of Semaglutide Subcutaneous Depot for Weight Reduction in Adults with Obesity or Overweight
GermanyStudy of long-term safety of octreotide subcutaneous depot (CAM2029) in patients with acromegaly
GermanyStudy on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors
BelgiumStudy on Octreotide for Patients with Symptomatic Polycystic Liver Disease
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
